Fast Market Research

"EU Biosimilars Database" Now Available at Fast Market Research

New Pharmaceuticals research report from Datamonitor is now available from Fast Market Research


Boston, MA -- (SBWIRE) -- 10/23/2012 -- Details of all marketed and pipeline biosimilars in the EU. View by product, selecting a molecule name; assess a biosimilar company's pipeline; or view the full pipeline and filter on all 11 labels.

- Pipeline: details of the full pipeline of products, select all or filter by country and sort by a variety of criteria
- Product: select an individual product and view details of all associated biosimilars in development in the EU
- Company: select either a biosimilar source company or a partner company to view details of all biosimilar products in its EU portfolio


Database of marketed and pipeline biosimilars in the EU, based on company-reported information and a variety of other sources.

Reasons to Get this Report
- Identify which products are being targeted by biosimilars developers and which companies are active in the EU biosimilars market
- Analyze the pipeline of biosimilar products in development in the EU by therapy area, molecule type and company amongst other criteria

View Full Report Details and Table of Contents

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth
- Biosimilars: Global Regulatory Update
- Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
- Global Biosimilars: A return to optimism?
- Pharmaceutical Key Trends 2011 - Biosimilar Market Overview
- Celltrion: Biosimilars Company Analysis
- The Pharmaceutical Market: Poland
- The Pharmaceutical Market: Portugal
- The Pharmaceutical Market: Ireland
- The Pharmaceutical Market: Greece